We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Atlantic Lithium Limited | LSE:ALL | London | Ordinary Share | AU0000237554 | ORD NPV (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.10 | 0.50% | 20.00 | 20.05 | 20.50 | 20.50 | 20.35 | 20.35 | 439,121 | 16:35:23 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Iron Ores | 0 | -12.19M | -0.0200 | -10.25 | 124.89M |
Date | Subject | Author | Discuss |
---|---|---|---|
11/9/2012 08:37 | I've built up a holding over the last month at around 72-74p. Always liked the business. | wjccghcc | |
10/9/2012 21:38 | Nope, I haven't held for a while as the shareprice never seemed to go anywhere. I still pop in now and then just to see how things are going. Good luck. | jakleeds | |
10/9/2012 21:33 | There's been very few posts at all('scuse the pun) for this share. Any of you previous posters still holding? It seems there's very very few shares in free float. With the recommencement of divis this could be a humdinger! | devil20 | |
07/9/2012 12:33 | I see there's been no posts here for a few weeks. This has been tipped today by MoneyWeek who think it MAY be snapped up by a bigger fish. So I've taken a few. | devil20 | |
03/8/2012 13:28 | Allocate Software's (LON:ALL) latest purchase, RealTime Health may match the revenues of its core business in under five years, according to chief executive Ian Bowles. Allocate is paying £1.2 mln upfront, followed by performance payments of up to a further £6 mln, for the hospital bed software group. | lucky_punter | |
03/8/2012 10:56 | Wanted to share this interesting audio interview with you guys. Ian Bowles, Chief Executive Officer of Allocate Software | sammy_smith | |
31/7/2012 13:01 | Staff rostering software specialist Allocate Software (LON:ALL) has posted record revenues for the sixth year in a row. Turnover rose by more in the fifth to £36.6 mln in the year to May, with all businesses said to be going well and the group re-introducing a dividend with a 1.2 pence final payment. | lucky_punter | |
31/7/2012 08:06 | Brilliant set of results this morning for Allocate software - smashing expectations. Dividends start flowing and fascinating new acquisition of patient flow management system. Is this the most undervalued company in the FTSE? | king_roster_iii | |
24/2/2012 12:33 | Interesting ALLOCATE SOFTWARE was 74p when this was published: now it's 87p..still more upside according to brokers. company makes more money when economy in trouble..jobless 3mln..oh boy are we in trouble. | ipoman2 | |
07/2/2012 10:52 | Staff rostering specialist Allocate Software (LON:ALL) said today underlying revenues grew in its latest half-year as momentum continued to build in its core NHS market. Revenues overall rose to £16 million from £15.9 million in the half year to November, with underlying sales up by 15% excluding acquisitions and a £3 million contract in Australia in the previous year. | lucky_punter | |
09/1/2012 13:07 | Allocate Software - Healthy start Click for report 1:05 PM | texas tea | |
25/11/2011 09:42 | Ageing populations, growing demand for treatment and cuts to healthcare budgets are problems that face hospitals all across the developed world. The pressure is providing an opportunity for IT companies specialising in the health arena such as staff rostering specialist Allocate Software (LON:ALL). | lucky_punter | |
11/11/2011 07:39 | From todays SEC announcement The key positive contributors to performance in the period were Allocate, Vintage and Pinewood, which rose 4%, 11% and 2% respectively. Allocate released final results ahead of expectations and forecasts were upgraded. Although this has been a successful investment so far for the SEC, we believe that the considerable progress made over the past two years has failed to be fully reflected in its share price. Since May, we have increased our holding by about 45%. Vintage's movement was a result of the strong performance in its highly diversified private equity portfolios. | the shuffle man | |
06/9/2011 12:50 | Looks like a good set of final figures with an encouraging statement. Be interested to see the semi official "analysts forecasts" for the current year. Only grouse I ever have, although it applies to almost every acquisitive company, is when advisers consider it almost mandatory to include in the official acquisitive documents the statement that "in terms of eps the acquisition will be enhancing in the first year". However then there seems to be a drag on earnings in the second year!It's just a general grouse. Pity about the share price but it is a bear market however short-or long! | gregmorg | |
15/7/2011 10:56 | Interview with Ian Bowles - | rockafella2 | |
31/3/2011 09:15 | Thanks n1blet. There was a fortnightly magazine called Techmark years ago(when I was alive!) and it was very authoritative. The one you refer to is from a new organisation according to its site and which appears to aim to be precisely that. Not quite what I expected when you referred to analysts which I had assumed referred to "sell side". Still all comment spreads the word and the more write ups the better!. | gregmorg | |
30/3/2011 02:16 | gregmorg they are, followers of the whole IT world:- Techmarketview | n1blet | |
23/3/2011 10:44 | n1blet. Purely for my added information what analyst comment are you referring to?Numis is the shop whilst Edison is a paid research house. If there are others researching the stock as well then that would be excellent in terms of spreading the word as this tiddler grows.I await your reponse. | gregmorg | |
22/3/2011 23:49 | analyst comment, that they are def producing what the NHS needs, to achieve cost saving, but with the abolition of PHT's & setting up of GP consortia's, there is some hiatus amongst the signers off of contracts, whilst contract growth is running despite all this at 30%pa. + overall inotherwards, Not read rec above yet, but looks to still be very low profile as a business. | n1blet | |
22/3/2011 10:59 | Yesterday's 3rd qtr update was fine other than reading between the lines there seemed a touch of caution re timing of contracts being signed off. Whether that is the forerunner of something else is at this stage unknown but it obviously has caused a little concern. It seems that recent momentum has slowed but given the background that is hardly surprising.Still, fingers crossed for the longer term! | gregmorg |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions